Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Automating Timekeeping for a Smarter and More Efficient Workplace

    May 1, 2023

    Here are 5 ways in which Web 3.0 will change online advertising

    February 18, 2023

    Штори та занавіски IKEA – широкий вибір, низька ціна та простота монтажу

    April 28, 2023
    Facebook Twitter Instagram
    TecheDirt
    • Home
    • Business
    • Technology
      • Tech Geek
    • Education
      • Digital Marketing
    • Lifestyle
      • Fashion
      • Health
    • News
      • Politics
    • Contact
    Facebook Twitter Instagram
    TecheDirt
    Home»Lifestyle»Effects of lifestyle modification orlistat and dietary experimentation for people who are overweight and have metabolic syndrome related fatty liver disease
    Lifestyle

    Effects of lifestyle modification orlistat and dietary experimentation for people who are overweight and have metabolic syndrome related fatty liver disease

    Daniel HarrisonBy Daniel HarrisonFebruary 15, 2023No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    lifestyle modification
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Background

    About a third of the world’s population suffers from metabolic-associated fatty liver disease (MAFLD), characterised by an abnormal accumulation of lipids in the liver. Unfortunately, there are currently no FDA-approved pharmaceutical treatments for MAFLD, so lifestyle interventions are the primary method of weight management treatment.

    Unfortunately, this method is only successful for about a third of MAFLD patients. Therefore, new approaches have emerged to treat MAFLD, including pharmacotherapy, dietary interventions, and bariatric surgery.

    There is evidence that following a Mediterranean diet that emphasises healthy fats like omega-3 and monounsaturated fats while cutting back on carbohydrates can help you lose weight and prevent fat from being produced in the liver. Furthermore, it has been shown to ameliorate liver injuries in fatty liver diseases, lessen insulin resistance, and lessen fat accumulation in the liver. Moreover, the number of helpful gut microbiota might increase if you eat a diet high in fibre.

    Clinical trials of the weight loss drug orlistat have shown promising results in reducing liver steatosis in obese adults with nonalcoholic fatty liver disease. Orlistat has the potential to be an effective nutritional therapy for MAFLD, but comparative studies with other approaches are needed.

    Study background

    Study background

    Patients with MALFD who had been diagnosed with the help of an MRI-based proton density fat fraction (MRI-PDFF) analysis participated in this open-label, prospective, single-center study. Participants had to be between the ages of 18 and 60, have a BMI of at least 25 kg/m2, and not have lost more than 3% of their body weight due to self-lifestyle interventions in order to be included.

    Certain medications known to cause fatty liver were also excluded, as were heavy drinkers, those with serious heart, lung, or kidney diseases, women who were pregnant or nursing, those with autoimmune liver disease, those with viral hepatitis, and those with secondary liver steatosis.

    The subjects were evenly distributed among the orlistat, control, and experimental diet groups. Each day, subjects in the control group ate 60 grammes of a standard meal replacement powder and were instructed to eat 500 to 1,000 fewer calories than usual.

    Also Read : Capturing carbon emissions and the next ecological step

    Participants in the orlistat group took 120 mg of orlistat three times daily, while those in the experimental diet group consumed 60 grammes of experimental meal replacement powder. The people in the experimental diet group were given instructions on how to eat like the Mediterranean diet, which is high in fibre and low in glycemic index. Everyone who took part was tasked with working out three times weekly for a total of 90 minutes.

    A hepatology doctor and a registered dietitian worked together to provide the follow-up care. Participants were instructed to use the WeChat app to keep track of what they ate three times a day, and family members were strongly encouraged to join in. At weeks 0-4 and 12-24, participants returned to the clinics for additional anthropometric measurements and blood work.

    Results

    Liver fat content (LFC) was found to be lower in the orlistat and experimental diet groups compared to the control group by study’s end. Overall, the LFC levels dropped by 9.1% in the orlistat group and 5.4% in the experimental diet group. T

    Weight, body mass index, waist circumference, and abdominal circumference all decreased in the experimental diet group. All the same, the orlistat group showed the most progress with regards to these markers when compared to the other groups.

    The study also discovered a marked difference in the groups’ distributions of liver steatosis grades, with the orlistat group having the fewest subjects with extremely severe liver steatosis. In addition, compared to the experimental diet group (43.6%) and the control group (33.3%), 80% of orlistat group participants improved by at least one grade in liver steatosis. The LFC dropped by 27.9% in the orlistat group by week 24, compared to a 17.4% drop in the control group.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Daniel Harrison
    Daniel Harrison

    As a blogger and creative writer, I strive to create content that not only informs but also entertains. My passion for SEO allows me to ensure that my writing is seen by as many people as possible. I believe that everyone has a story worth telling, and I am dedicated to helping others share theirs.

    Related Posts

    Штори та занавіски IKEA – широкий вибір, низька ціна та простота монтажу

    April 28, 2023

    Find Parks in Your Neighborhood

    March 31, 2023

    Predictions for the Month of February 2023 Make Your Dreams Come True

    February 5, 2023

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    New In
    Fashion

    Lizzo Doeja Cat’s Red Carpet Style at the Grammys

    By Daniel Harrison
    Lifestyle

    Predictions for the Month of February 2023 Make Your Dreams Come True

    By Daniel Harrison
    Technology

    Rare brain tumour spies masquerading as healthy cells are exposed by cutting edge technology

    By Daniel Harrison
    Tech Geek

    Clubhouse’s latest round values the startup at $4B

    By Daniel Harrison
    About Us
    About Us

    Unlocking the secrets of technology.

    Our Picks

    The University of California San Diego Is Dedicated To Providing Its Students With Diverse International Opportunities

    February 10, 2023

    Twilio CEO Jeff Lawson calls out tech leaders for bailing on SF and being rude about it as they leave, says he is staying and working to make the city better

    April 1, 2023

    SEC filing: Voodoo PC founder Rahul Sood’s Irreverent Labs, which unveiled its NFT robot cock fighting game MechaFightClub in January 2022, raised $40M

    April 1, 2023
    Editor Choice

    Lizzo Doeja Cat’s Red Carpet Style at the Grammys

    February 6, 2023

    Always on the lookout for the next health threat a discussion with Dr Richard Molenkamp of Erasmus Medical Center’s Department of Viroscience

    January 24, 2023

    Facebook Oversight Board member told UK Parliament that the panel feels constrained when reviewing decisions on a case-by-case basis, may seek algorithm access

    March 3, 2023
    Facebook Twitter Instagram Pinterest
    • Home
    • Business
    • Fashion
    • Lifestyle
    • Technology
    • News
    • Get In Touch
    • Follow Publication
    © 2023 TecheDirt. - All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.